<DOC>
	<DOCNO>NCT00169299</DOCNO>
	<brief_summary>Surveys indicate 25 33 % woman moderate severe menopausal symptom include hot flash , night sweat , disturbed sleep . The treatment choice medical community symptom hormone replacement therapy , estrogen sometimes progestin . Many woman also use over-the-counter herbal remedy . However , less know well product work , safety . Few undergone kind rigorous testing require prescription drug little known long-term effectiveness relieving symptom . The purpose study compare several over-the-counter herbal remedy hormone replacement therapy . Our primary aim look effect remedy self-reported menopausal symptom . We also measure effect factor know affect hormone replacement therapy : cholesterol , blood sugar , bone density , vaginal cell structure , blood clotting .</brief_summary>
	<brief_title>Herbal Alternatives Menopause Symptoms ( HALT Study )</brief_title>
	<detailed_description>Hormone replacement therapy ( HT : estrogen progestin ) remain treatment choice woman vasomotor symptom , long-term HT recommend prevention purpose . The demand alternative HT , availability use over-the-counter product include dietary phytoestrogen supplement , naturopathic medicine grow dramatically . Few product face rigor randomize trial none test evaluate effect long-term outcome . The purpose 4-year , randomize control trial evaluate efficacy safety three alternative approach utilize phytoestrogens treat vasomotor symptoms peri- postmenopausal woman . The treatment choose scientific evidence support possible benefit , availability product adequate quality control , frequency use naturopathic medicine , ability blind participant intervention . The 5 propose treatment arm : 1 ) conjugate equine estrogen without medroxyprogesterone acetate woman without intact uterus respectively ; 2 ) single herbal product , black cohosh ; 3 ) multibotanical preparation ; 4 ) combination regimen include multibotanical preparation plus soy diet counseling ; 5 ) placebo . Our primary aim compare effect three alternative treatment , HRT placebo frequency intensity vasomotor symptom measure The Wiklund Menopause Symptom Checklist daily Vasomotor Symptom Diary . Our secondary aim compare effect three alternative treatment , HRT placebo : 1 ) vaginal cytology ( vaginal maturation index ) ; 2 ) serum lipid ( total cholesterol , HDL LDL cholesterol , triglyceride ) ; 3 ) bone mineral density ( hip spine dual energy x-ray absorptiometry scan ) ; 4 ) glucose metabolism ( insulin , fast blood glucose ) ; 5 ) coagulation factor ( fibrinogen , PAI-1 ) . Our hypothesis compare placebo , three alternative treatment test proposal ; reduce frequency hot flash night sweat , improve vaginal maturation decrease vagina atrophy measure maturation index , low total cholesterol LDL effect HDL , reduce rate decline bone mineral density ( BMD ) , effect glucose metabolism clot factor . To accomplish specific aim : 1 ) recruit randomize approximately peri- post-women one 5 treatment arm one year ; 2 ) collect measurement primary secondary outcome baseline , 3 , 6 , 12 month ; 3 ) compare change outcomes group take alternative treatment HRT placebo group .</detailed_description>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<criteria>female age 45 55 peri postmenopausal moderate severe vasomotor symptom normal thyroid stimulate hormone proof normal mammogram within past 2 year use HT oral contraceptive within past 3 month use herbs alternative complementary medicine vasomotor symptom within past 1 month medical history contraindication HT bone mineral density great 2 standard deviation age specific mean bilateral oophorectomy current use tamoxifen , raloxifene , bisphosphonates , cholesterollowering medication , prescription bloodthinners , oral steroid pregnant plan become pregnant allergy soybean soy protein unable swallow pill current participation another investigational drug trial intention move area next 12 month noncompliance procedure involve screen runin trial</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Vasomotor</keyword>
	<keyword>Black cohosh</keyword>
	<keyword>Herbs</keyword>
	<keyword>Hot flash</keyword>
	<keyword>HT</keyword>
	<keyword>CAM</keyword>
</DOC>